- Company Overview for INGENOX THERAPEUTICS LIMITED (14127227)
- Filing history for INGENOX THERAPEUTICS LIMITED (14127227)
- People for INGENOX THERAPEUTICS LIMITED (14127227)
- Registers for INGENOX THERAPEUTICS LIMITED (14127227)
- More for INGENOX THERAPEUTICS LIMITED (14127227)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
17 Jan 2023 | SH01 |
Statement of capital following an allotment of shares on 22 December 2022
|
|
16 Jan 2023 | PSC07 | Cessation of Nicholas Barrie La Thangue as a person with significant control on 22 December 2022 | |
16 Jan 2023 | AP01 | Appointment of David James Kerr as a director on 22 December 2022 | |
16 Jan 2023 | AP01 | Appointment of Mr Nicholas George Dixon-Clegg as a director on 22 December 2022 | |
16 Jan 2023 | AP01 | Appointment of Dr Simon Kerry as a director on 22 December 2022 | |
16 Jan 2023 | SH01 |
Statement of capital following an allotment of shares on 22 December 2022
|
|
16 Jan 2023 | RESOLUTIONS |
Resolutions
|
|
16 Jan 2023 | MA | Memorandum and Articles of Association | |
24 May 2022 | NEWINC |
Incorporation
Statement of capital on 2022-05-24
|